New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a … M Papp, I Altorjay, N Dotan, K Palatka, I Foldi, J Tumpek, S Sipka, ... Official journal of the American College of Gastroenterology| ACG 103 (3 …, 2008 | 176 | 2008 |
Shielding of the A1 domain by the D′ D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V H Ulrichts, M Udvardy, PJ Lenting, I Pareyn, N Vandeputte, ... Journal of Biological Chemistry 281 (8), 4699-4707, 2006 | 173 | 2006 |
Complement activation in thrombotic thrombocytopenic purpura M Reti, P Farkas, D Csuka, K Razso, A Schlammadinger, ML Udvardy, ... Journal of Thrombosis and Haemostasis 10 (5), 791-798, 2012 | 167 | 2012 |
Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections M Papp, Z Vitalis, I Altorjay, I Tornai, M Udvardy, J Harsfalvi, A Vida, ... Liver International 32 (4), 603-611, 2012 | 141 | 2012 |
Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial J Trotman, SF Barrington, D Belada, M Meignan, R MacEwan, C Owen, ... The Lancet Oncology 19 (11), 1530-1542, 2018 | 125 | 2018 |
Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in … T Robak, J Jin, H Pylypenko, G Verhoef, N Siritanaratkul, J Drach, ... The Lancet Oncology 19 (11), 1449-1458, 2018 | 117 | 2018 |
Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies … N Gagelmann, DJ Eikema, S Iacobelli, L Koster, H Nahi, AM Stoppa, ... haematologica 103 (5), 890, 2018 | 101 | 2018 |
Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease PL Lakatos, LS Kiss, K Palatka, I Altorjay, P Antal-Szalmas, E Palyu, ... Inflammatory bowel diseases 17 (3), 767-777, 2011 | 98 | 2011 |
The possible association of in vivo leukocyte-platelet heterophilic aggregate formation and the development of diabetic angiopathy M Kaplar, J Kappelmayer, A Veszpremi, K Szabo, M Udvardy Platelets 12 (7), 419-422, 2001 | 94 | 2001 |
Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype … M Papp, I Altorjay, GL Norman, Z Shums, K Palatka, Z Vitalis, I Foldi, ... Inflammatory bowel diseases 13 (8), 984-992, 2007 | 92 | 2007 |
Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia A Molvarec, J Rigó Jr, T Bõze, Z Derzsy, L Cervenak, V Makó, T Gombos, ... Thrombosis and haemostasis 101 (02), 305-311, 2009 | 90 | 2009 |
Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not … PL Lakatos, I Altorjay, T Szamosi, K Palatka, Z Vitalis, J Tumpek, S Sipka, ... Inflammatory bowel diseases 15 (3), 365-374, 2009 | 88 | 2009 |
Interaction of factor XIII subunits E Katona, K Pénzes, A Csapó, F Fazakas, ML Udvardy, Z Bagoly, ... Blood, The Journal of the American Society of Hematology 123 (11), 1757-1763, 2014 | 79 | 2014 |
European perspective on multiple myeloma treatment strategies: update following recent congresses H Ludwig, H Avet‐Loiseau, J Bladé, M Boccadoro, J Cavenagh, M Cavo, ... The Oncologist 17 (5), 592-606, 2012 | 79 | 2012 |
Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease K Palatka, Z Serfőző, Z Veréb, Z Hargitay, B Lontay, F Erdődi, G Bánfalvi, ... Scandinavian journal of gastroenterology 40 (6), 670-680, 2005 | 77 | 2005 |
The association of reduced endothelium derived relaxing factor-NO production with endothelial damage and increased in vivo platelet activation in patients with diabetes mellitus M Huszka, M Kaplar, L Rejto, I Tornai, K Palatka, P Laszlo, M Udvardy Thrombosis research 86 (2), 173-180, 1997 | 73 | 1997 |
Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension J Vegh, P Szodoray, J Kappelmayer, I Csipo, M Udvardy, G Lakos, ... Scandinavian journal of immunology 64 (1), 69-76, 2006 | 71 | 2006 |
Presence of anti-microbial antibodies in liver cirrhosis–a tell-tale sign of compromised immunity? M Papp, GL Norman, Z Vitalis, I Tornai, I Altorjay, I Foldi, M Udvardy, ... PLoS One 5 (9), e12957, 2010 | 67 | 2010 |
Plasma levels of beta-thromboglobulin and factor VIII-related antigen in diabetic children and adults K Rak, P Beck, M Udvardy, G Pfliegler, M Misz, Z Boda Thrombosis Research 29 (2), 155-162, 1983 | 53 | 1983 |
Platelet insulin receptor determination in non-insulin dependent diabetes mellitus M Udvardy, G Pfliegler, K Rak Experientia 41 (3), 422-423, 1985 | 52 | 1985 |